Targeting MYC-driven replication stress in medulloblastoma with AZD1775 and gemcitabine
Daniel C. Moreira(St. Jude Children's Research Hospital), Rajeev Vibhakar(Children's Hospital Colorado), Charles G. Eberhardt(Johns Hopkins University), Adam Green(Morgan Adams Foundation), Nicholas K. Foreman(Morgan Adams Foundation), Ilango Balakrishnan(Morgan Adams Foundation), Sujatha Venkataraman(University of Colorado Anschutz Medical Campus), Angela Pierce(University of Colorado Anschutz Medical Campus), John DeSisto(Morgan Adams Foundation), Eric Prince(Colorado School of Public Health), Andrea M. Griesinger(Morgan Adams Foundation), Apurva Subramanian(University of Colorado Anschutz Medical Campus)
Cited by 18
Related Papers
Intertumoral Heterogeneity within Medulloblastoma Subgroups
|Cancer Cell|2017|1.3k
Factors Associated With Death in Critically Ill Patients With Coronavirus Disease 2019 in the US
|JAMA Internal Medicine|2020|1k
Genomic analysis of diffuse intrinsic pontine gliomas identifies three molecular subgroups and recurrent activating ACVR1 mutations
|Nature Genetics|2014|654
Association Between Early Treatment With Tocilizumab and Mortality Among Critically Ill Patients With COVID-19
|JAMA Internal Medicine|2020|555